# NextPoint Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nextpoint-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.nextpointtx.com/
- Total disclosed funding: $80M
- Latest round: Series B (Dec 13, 2022)
- Investors on record: 8

## About

Based in Massachusetts, US, and founded in 2020 by XingXing Zang and Gordon Freeman, NextPoint Therapeutics, Inc., operates as a biotechnology research company that offers various therapeutic solutions. In December 2022, NextPoint Therapeutics, Inc., raised USD 80 million in Series B funding, co-led by investors Leaps by Bayer and Sanofi Ventures, with participation from other investors Catalio Capital Management, Invus, PagodaTree Partners, and Sixty Degree Capital. As of 2023, the company is led by its CEO, Detlev Biniszkiewicz, and has partnered with companies like Simcere, Invus, Dana-Farber Cancer Institute, and many more.

The company offers immunotherapy solutions that include novel therapeutic strategies used for the treatment of cancer. The company delivers a new class of monotherapies by providing an approach that integrates foundational science with a defined clinical biomarker and HHLA2 expression. Its approach reactivates immune cells in tumors that are suppressed by HHLA2-driven immune evasion.

The company plans to use the December 2022 funding to support its product development.

## Funding rounds

- Series B, Dec 13, 2022, $80M — Invus [DUP], MPM BioImpact, Sanofi Ventures, Leaps by Bayer, Catalio Capital Management, Sixty Degree Capital, Binney Street Capital, PagodaTree Partners

## Investors

- Invus [DUP] — Series B
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series B
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series B
- Leaps by Bayer (https://capitalatlas.ai/funds/leaps-by-bayer) — Series B
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series B
- Sixty Degree Capital (https://capitalatlas.ai/funds/sixty-degree-capital) — Series B
- Binney Street Capital (https://capitalatlas.ai/funds/binney-street-capital) — Series B
- PagodaTree Partners (https://capitalatlas.ai/funds/pagodatree-partners) — Series B